RONALD HALL: Open Payments
NPI 1700281516 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,671 in 165 payments from 18 companies in 2025. Trend: 2023 $2,790 · 2024 $3,182 · 2025 $3,671
Food & beverage: $3,616Education: $55
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $603 |
| Otsuka America Pharmaceutical, Inc. | 27 | $598 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $319 |
| E.R. Squibb & Sons, L.L.C. | 11 | $303 |
| Alkermes, Inc. | 15 | $259 |
| Corium, LLC | 11 | $226 |
| Collegium Pharmaceutical, Inc. | 12 | $210 |
| Lundbeck LLC | 11 | $188 |
| ABBVIE INC. | 10 | $171 |
| Vanda Pharmaceuticals Inc. | 7 | $166 |
Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, ARISTADA, Azstarys, Jornay PM, VRAYLAR.
Industry payments across TX — which companies pay providers there.
